Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Dr. Lal PathLabs Limited ( (IN:LALPATHLAB) ).
Dr. Lal PathLabs Limited has announced an amendment to its Memorandum of Association (MOA) following approval from its members via a postal ballot. The amendment involves an increase in the company’s authorized share capital from INR 107.96 crore to INR 200 crore, which is expected to enhance the company’s financial capacity and potentially support future growth initiatives.
More about Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited operates in the healthcare industry, specializing in diagnostic and related healthcare tests. The company is a leading provider of pathology and diagnostic services in India, catering to a wide range of medical testing needs for patients and healthcare providers.
Average Trading Volume: 5,474
Technical Sentiment Signal: Buy
Current Market Cap: 253.5B INR
For a thorough assessment of LALPATHLAB stock, go to TipRanks’ Stock Analysis page.